Showing 1 - 10 of 19
Resource use measures, including forms, diaries and questionnaires, are ubiquitous in trial‐based economic evaluations in the UK. However, there are concerns about the accuracy of how they are described, which limits the transparency of reporting. We developed a simple and structured taxonomy...
Persistent link: https://www.econbiz.de/10011160870
Persistent link: https://www.econbiz.de/10009506726
Recent epidemiological studies suggest that much urological disease is untreated. However, the overall economic burden of urological diseases has never been systematically studied. This report estimates the economic burden of treated benign prostatic hyperplasia (BPH) in the United Kingdom by...
Persistent link: https://www.econbiz.de/10009439532
Background Provision of evidence on costs alongside evidence on the effects of interventions can enhance the relevance of systematic reviews to decision-making. However, patterns of use of economics methods alongside systematic review remain unclear. Reviews of evidence on the effects of...
Persistent link: https://www.econbiz.de/10009440624
The last twenty years has seen a substantial growth in the literature on economic evaluation in health care. In addition, since Australia made economic evaluation an important component of its decision making process on the reimbursement of drugs in 1993, several jurisdictions have adopted...
Persistent link: https://www.econbiz.de/10013018013
Objective: The objective of this paper is to examine how well the QALY captures the health gains generated by cancer treatments, with particular focus on the methods for constructing QALYs preferred by NICE. Methods: Data were obtained using a keyword search of the MEDLINE database and a hand...
Persistent link: https://www.econbiz.de/10013018938
Persistent link: https://www.econbiz.de/10012665572
The increased pressures on health care budgets have emphasised the need to demonstrate the value for money from health technologies. Most major pharmaceutical companies have therefore commissioned cost-benefit or cost-effectiveness analysis of their products. There is an assumed analogy between...
Persistent link: https://www.econbiz.de/10005344464
Critical leg ischaemia can be treated by amputation of the affected leg or by reconstruction of the arteries. Arterial reconstruction is perceived to be an expensive procedure, often requiring more than one operation, which does not always prevent amputation. However, amputation is associated...
Persistent link: https://www.econbiz.de/10005344485
Despite the growth in published studies year on year, and its adoption as a formal requirement in some jurisdictions, there are still doubts about whether economic evaluation is really useful in health care decision making. This article considers evidence for and against the proposition that...
Persistent link: https://www.econbiz.de/10014072502